Chronic rubidium does not prevent dopamine receptor supersensitivity

J. Bannet, R. P. Ebstein, M. Hershkowitz, R. H. Belmaker

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Unlike lithium, chronic rubidium does not prevent the halopridol-induced increase in spiperone binding. Moreover, unlike other antidepressants, chronic rubidium does not reduce dihydroalprenolol binding.

Original languageEnglish
Pages (from-to)281-283
Number of pages3
JournalNeuropsychobiology
Volume8
Issue number6
DOIs
StatePublished - 1 Jan 1982
Externally publishedYes

Fingerprint

Dive into the research topics of 'Chronic rubidium does not prevent dopamine receptor supersensitivity'. Together they form a unique fingerprint.

Cite this